MONOCLONAL ANTIBODY N16-F2 SPECIFIC TO HUMAN NAIVE PLURIPOTENT STEM CELLS
The present invention relates to: a monoclonal antibody specifically binding to human naive pluripotent stem cells; and a hybridoma producing same and, particularly to: monoclonal antibody N16-F2, which binds to human naive pluripotent stem cells but not to human primed pluripotent stem cells or has...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French Korean |
Published |
30.04.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to: a monoclonal antibody specifically binding to human naive pluripotent stem cells; and a hybridoma producing same and, particularly to: monoclonal antibody N16-F2, which binds to human naive pluripotent stem cells but not to human primed pluripotent stem cells or has significantly weak binding capacity; hybridoma N16-F2 for producing the monoclonal antibody; an assay kit comprising monoclonal antibody N16-F2; and a composition for removing human pluripotent stem cells.
La présente invention concerne : un anticorps monoclonal se liant de manière spécifique à des cellules souches pluripotentes naïves humaines ; et un hybridome produisant celui-ci ; l'invention concerne en particulier : un anticorps monoclonal N16-F2, qui se lie à des cellules souches pluripotentes naïves humaines mais pas à des cellules souches pluripotentes sensibilisées humaines ou qui a une capacité de liaison significativement faible ; un hybridome N16-F2 permettant de produire l'anticorps monoclonal ; un kit de dosage comprenant l'anticorps monoclonal N16-F2 ; et une composition permettant d'éliminer les cellules souches pluripotentes humaines.
본 발명은 인간 순수 만능줄기세포 (human naive pluripotent stem cell)에 특이적으로 결합하는 단일클론항체 및 이를 생산하는 하이브리도마에 관한 것으로서, 구체적으로는 인간 순수만능줄기세포에는 결합하고 인간 준 만능줄기세포에는 결합하지 않거나 결합력이 현저히 약한 단일클론항체 N16-F2, 상기 단일클론항체를 생산하는 하이브리도마 N16-F2, 상기 단일클론항체 N16-F2를 포함하는 검정키트 및 인간 만능줄기세포 제거용 조성물에 관한 것이다. |
---|---|
AbstractList | The present invention relates to: a monoclonal antibody specifically binding to human naive pluripotent stem cells; and a hybridoma producing same and, particularly to: monoclonal antibody N16-F2, which binds to human naive pluripotent stem cells but not to human primed pluripotent stem cells or has significantly weak binding capacity; hybridoma N16-F2 for producing the monoclonal antibody; an assay kit comprising monoclonal antibody N16-F2; and a composition for removing human pluripotent stem cells.
La présente invention concerne : un anticorps monoclonal se liant de manière spécifique à des cellules souches pluripotentes naïves humaines ; et un hybridome produisant celui-ci ; l'invention concerne en particulier : un anticorps monoclonal N16-F2, qui se lie à des cellules souches pluripotentes naïves humaines mais pas à des cellules souches pluripotentes sensibilisées humaines ou qui a une capacité de liaison significativement faible ; un hybridome N16-F2 permettant de produire l'anticorps monoclonal ; un kit de dosage comprenant l'anticorps monoclonal N16-F2 ; et une composition permettant d'éliminer les cellules souches pluripotentes humaines.
본 발명은 인간 순수 만능줄기세포 (human naive pluripotent stem cell)에 특이적으로 결합하는 단일클론항체 및 이를 생산하는 하이브리도마에 관한 것으로서, 구체적으로는 인간 순수만능줄기세포에는 결합하고 인간 준 만능줄기세포에는 결합하지 않거나 결합력이 현저히 약한 단일클론항체 N16-F2, 상기 단일클론항체를 생산하는 하이브리도마 N16-F2, 상기 단일클론항체 N16-F2를 포함하는 검정키트 및 인간 만능줄기세포 제거용 조성물에 관한 것이다. |
Author | RYU, Chun Jeih CHOI, Hong Seo SEO, Se Ri |
Author_xml | – fullname: SEO, Se Ri – fullname: RYU, Chun Jeih – fullname: CHOI, Hong Seo |
BookMark | eNqNyrsKwjAUANAMOvj6hwvOhTSlxTXGhAaSe4tJFadSJE6SFur_4-IHOJ3lbNkqTzltmPWEpByhdCAx2jNdHoBlUxgBodPKGqsgErS9lwgo7U1D5_qr7ShqjBCi9qC0c2HP1q_xvaTDzx07Gh1VW6R5GtIyj8-U02e4k-CC81NdN5Usq__WF-yXL4k |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences Physics |
DocumentTitleAlternate | ANTICORPS MONOCLONAL N16-F2 SPÉCIFIQUE DIRIGÉ CONTRE DES CELLULES SOUCHES PLURIPOTENTES NAÏVES HUMAINES 인간 순수 만능줄기세포에 특이적인 단일클론항체 N16-F2 |
ExternalDocumentID | WO2020085563A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO2020085563A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:38:41 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French Korean |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO2020085563A13 |
Notes | Application Number: WO2018KR13634 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200430&DB=EPODOC&CC=WO&NR=2020085563A1 |
ParticipantIDs | epo_espacenet_WO2020085563A1 |
PublicationCentury | 2000 |
PublicationDate | 20200430 |
PublicationDateYYYYMMDD | 2020-04-30 |
PublicationDate_xml | – month: 04 year: 2020 text: 20200430 day: 30 |
PublicationDecade | 2020 |
PublicationYear | 2020 |
RelatedCompanies | INDUSTRY ACADEMY COOPERATION FOUNDATION OF SEJONG UNIVERSITY |
RelatedCompanies_xml | – name: INDUSTRY ACADEMY COOPERATION FOUNDATION OF SEJONG UNIVERSITY |
Score | 3.243511 |
Snippet | The present invention relates to: a monoclonal antibody specifically binding to human naive pluripotent stem cells; and a hybridoma producing same and,... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PHYSICS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE |
Title | MONOCLONAL ANTIBODY N16-F2 SPECIFIC TO HUMAN NAIVE PLURIPOTENT STEM CELLS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200430&DB=EPODOC&locale=&CC=WO&NR=2020085563A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8Q_HxT1KCiaaLZ22LGRtkeiBldF2b2FRiIT4S2LDEaIDLjv287QHnisXfJpW1yX727XwEem1g4jDuGPsPC1i2Gc93mXOjcmTpGLjC3czUoHMW4N7Rexq1xBT63szAlTuhPCY4oNYpLfS9Ke738f8Tyyt7K1RN7l6TFs591PG2THTdLCCvN63ZomngJ0QiReZsW99c8W6FhuTJXOlCBtELap6OumktZ7joV_wwOUylvXpxD5WNRgxOy_XutBsfRpuRdg6OyR5OvJHGjh6sLCKQlTEioYGyRG2dBN_HeUGxg3W-iQUpJ4AcEZQnqDSM3RrEbjChKw2E_SJOMxhkaZDRChIbh4BIefJqRni53N_m7jMlrsnsU8wqq88V8VgfUVpkb48Jk7amVC9NhU8sQLRn-CWGZOb6Gxj5JN_vZt3Cqlus6SgOqxdf37E6644Ldl7f4C4Bjh6M |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8Q_MA3RY0fqE00e1vM2BjbAzGj67Lp1i1QEJ8Ia1liNEBkxn_fboDyxGsvubSX3F1_vbtfAR6aprBTbmvq1BSWaqRmplqcC5XbE1vLhMmtrBgUjqjpD4znUWtUgc_NLEzJE_pTkiNKj-LS3_MyXi_-H7Hcsrdy-Zi-y6X5k8c6rrJGx82Swkpxux2SxG6MFYwlblNobyWzCjYsR2KlvbYEhQXTPhl2i7mUxXZS8Y5hP5H6ZvkJVD7mdajhzd9rdTiM1iXvOhyUPZp8KRfXfrg8hUBGwhiHBY0tcigLurH7hqhmql4T9ROCAy_AiMXIH0QORdQJhgQl4aAXJDEjlKE-IxHCJAz7Z3DvEYZ9Ve5u_GeM8Wu8fRT9HKqz-Wx6AahdILeUCz1tT4xM6HY6MTTRktc_IQw9My-hsUvT1W7xHdR8FoXjMKAv13BUiFY1lQZU86_v6Y1MzXl6W1r0F_7Sio4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=MONOCLONAL+ANTIBODY+N16-F2+SPECIFIC+TO+HUMAN+NAIVE+PLURIPOTENT+STEM+CELLS&rft.inventor=SEO%2C+Se+Ri&rft.inventor=RYU%2C+Chun+Jeih&rft.inventor=CHOI%2C+Hong+Seo&rft.date=2020-04-30&rft.externalDBID=A1&rft.externalDocID=WO2020085563A1 |